Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test (Marketwire)

February 9th, 2010 by admin

SEATTLE, WA–(Marketwire – February 8, 2010) – Atossa Genetics , Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer , announced today the launch of its new Web site at www.atossagenetics.com .







Comments are closed.